Pure Global AI
NCT06301308Withdrawn

A Novel Application of 2% Lidocaine Injection for Male Rigid cycstoscopy-a Patient-blinded Randomised Trial

Second Xiangya Hospital of Central South UniversityPhase 3ClinicalTrials.govdrug
Verified
Study focus
Disease/Condition
Bladder Cancer
Drug/Device/Intervention
Intraurethral lidocaine gel alone
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Second Xiangya Hospital of Central South University
Location
Changsha, China
Timeline & enrollment
Phase
Phase 3
Start date
Oct 01, 2023
End date
Feb 29, 2024
Enrollment
0 participants
Primary outcome

Access the pain score using the Visual Analogue Scale (VAS)

Summary

The goal of this clinical trial is to learn about a novel application of lidocaine injection
 in male patients who needs rigid cycstoscopy test. The main question it aims to answer
 is:Does New Application of Lidocaine Liquid Provide Pain Relief for Patients During
 Cystoscopy? Before the cycstoscopy,Participants will be randomly divided into three different
 anesthesia mode groups,namely are Group A (intraurethral lidocaine gel alone), Group B
 (intraurethral lidocaine gel + lidocaine 2% injection), and Group C (intraurethral lidocaine
 gel + liquid paraffinl).Patients only need to prepare and cooperate according to routine
 surgical operations，which is group B or group C.

ICD-10 classifications
Malignant neoplasm of bladderMalignant neoplasm: Bladder, unspecifiedMalignant neoplasm: Dome of bladderMalignant neoplasm: Overlapping lesion of bladderMalignant neoplasm: Lateral wall of bladder
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06301308
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06301308 through Pure Global AI's free database. This Phase 3 trial is sponsored by Second Xiangya Hospital of Central South University and is currently Withdrawn. The study focuses on Bladder Cancer. Target enrollment is 0 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.